NDC properties for NDC 9 49502-417
NDC item 49502041702
| NDC 9 | 49502-417 |
|---|---|
| NDC 10 | 49502-417-02 |
| NDC Item | 49502041702 |
| packaging | 2 TRAY in 1 KIT (49502-417-02) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE (49502-484-06) * 2 PACKET in 1 KIT (49502-485-06) / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 762370 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
NDC item 49502041706
| NDC 9 | 49502-417 |
|---|---|
| NDC 10 | 49502-417-06 |
| NDC Item | 49502041706 |
| BLA | BLA761154 |
| FDA SPL set id | 762370 |
| Labeler | Mylan Specialty L.P. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-07-02 |
| Marketing status | ACTIVE |
NDC item 83257002042
| NDC 9 | 83257-020 |
|---|---|
| NDC 10 | 83257-020-42 |
| NDC Item | 83257002042 |
| packaging | 2 TRAY in 1 KIT (83257-020-42) / 1 KIT in 1 TRAY * 2 TRAY in 1 KIT / 1 SYRINGE in 1 TRAY / .4 mL in 1 SYRINGE * 2 PACKET in 1 KIT / 1 mL in 1 PACKET |
| BLA | BLA761154 |
| FDA SPL set id | 788036 |
| Labeler | Biocon Biologics Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2024-04-15 |
| Marketing status | ACTIVE |